Richard A. Miller MD - 20 Sep 2022 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role
President and CEO, Director
Signature
/s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller
Issuer symbol
CRVS
Transactions as of
20 Sep 2022
Net transactions value
+$16,253
Form type
4
Filing time
20 Sep 2022, 18:58:39 UTC
Previous filing
15 Aug 2022
Next filing
28 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRVS Common Stock Purchase $9,964 +12,300 +0.91% $0.8101 1,361,705 20 Sep 2022 By Trust F1
transaction CRVS Common Stock Purchase $2,214 +2,700 +0.2% $0.8200 1,364,405 20 Sep 2022 By Trust F1
transaction CRVS Common Stock Purchase $4,075 +5,000 +0.37% $0.8150 1,369,405 20 Sep 2022 By Trust F1
holding CRVS Common Stock 35,714 20 Sep 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.